A new dengue vaccine (TAK-003) now WHO recommended in endemic areas; what about travellers?-Reference-Cited by-同舟云学术

A new dengue vaccine (TAK-003) now WHO recommended in endemic areas; what about travellers?

Published:2023-10 Issue:7 Volume:30 Page:
ISSN:1195-1982
Container-title:Journal of Travel Medicine
language:en
Short-container-title:

Author:

Freedman David O¹²

Affiliation:

1. Division of Infectious Diseases , Gorgas Memorial Institute, , Birmingham, AL, USA

2. University of Alabama at Birmingham , Gorgas Memorial Institute, , Birmingham, AL, USA

Abstract

Qdenga (Takeda) is now WHO recommended for residents of highly endemic areas. Travellers from dengue non-endemic countries with previous travel-related dengue (any serotype) will benefit from TAK-003 vaccination to prevent a secondary dengue infection during future dengue risk travel. Dengue-naïve travellers have less potential benefit and use will remain discretionary for now.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://academic.oup.com/jtm/advance-article-pdf/doi/10.1093/jtm/taad132/53038385/taad132.pdf

Reference9 articles.

1. Global burden for dengue and the evolving pattern in the past 30 years;Yang;J Travel Med,2021

2. Causes of fever in returning travelers: a European multicenter prospective cohort study;Camprubí-Ferrer;J Travel Med,2022

3. Autochthonous dengue outbreak in Italy 2020: clinical, virological and entomological findings;Barzon;J Travel Med,2021

4. Three-year efficacy and safety of Takeda's dengue vaccine candidate (TAK-003);Rivera;Clin Infect Dis,2022

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Edging towards a third dengue vaccine;The Lancet Infectious Diseases;2024-08

2. Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis;Journal of Travel Medicine;2024-07-02

3. Enhancing Dengue Virus Production and Immunogenicity with Celcradle™ Bioreactor: A Comparative Study with Traditional Cell Culture Methods;Vaccines;2024-05-22

4. Determining force of infection for chikungunya to support vaccine policy development;The Lancet Infectious Diseases;2024-05

5. Novel chikungunya and dengue vaccines: travel medicine applications;Journal of Travel Medicine;2024-04-18